United BioSource Corporation   Report issue

For profit Phase 2 Phase 3
Founded: Blue Bell PA United States (2003)

Organization Overview

First Clinical Trial
2005
NCT00651833
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

United BioSource Corporation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 2)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Lung Neoplasms (Phase 2)

Melanoma (Phase 3)

Pancreatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 12